Literature DB >> 18080812

The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients.

Charalampos Dragonas1, Jan T Wagner, Hans J Heppner, Thomas Bertsch, Wolfgang Muhlberg, Susanne Wicklein, Andreas Pahl, Christine Diewald, Iouri Bachmakov, Cornel C Sieber, Martin F Fromm.   

Abstract

OBJECTIVE: Digitoxin is a known substrate of the efflux pump P-glycoprotein (gene name: ABCB1). P-glycoprotein expression was shown to be modulated by single nucleotide polymorphisms in the ABCB1 gene, but it remains unclear whether these polymorphisms influence digitoxin blood levels. Our objective was to examine the association of ABCB1 C3435T genotype and elevated serum digitoxin concentrations (SDC) in a cohort of 77 geriatric patients consecutively admitted to a geriatric department over a 12-month period.
METHODS: The impact of ABCB1 3435 CC, CT, and TT genotypes on SDC and SDC normalized for daily digitoxin dosage and body weight was assessed by multivariate regression analysis.
RESULTS: Among participants, 18 (23%) had the CC, 36 (47%) the CT, and 23 (30%) the TT genotype. Adjusting for relevant covariates, no significant association of ABCB1 C3435T genotype and SDC or normalized SDC was detected. Mean SDC was 22.4 ng/ml (95% CI 18.9-25.9) for the TT, 21.8 ng/ml (95% CI 18.1-25.5) for the CT, and 25.7 ng/ml (95% CI 20.6-30.8) for the CC genotype. The means for normalized SDC were 5.2 kg.l(-1) (95% CI 4.3-6.1) for the TT, 6.1 kg.l(-1) (95% CI 4.7-7.5) for the CT, and 6.2 kg.l(-1) (95% CI 4.6-7.7) for the CC genotype.
CONCLUSION: In this sample of frail geriatric patients, the impact of ABCB1 C3435T genotype on serum digitoxin concentration was not of major relevance. Regular monitoring of digitoxin blood levels and surveillance of appropriate drug use remain the best ways to prevent digitoxin intoxications in the elderly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080812     DOI: 10.1007/s00228-007-0418-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  35 in total

Review 1.  Role of transport proteins in drug absorption, distribution and excretion.

Authors:  A Ayrton; P Morgan
Journal:  Xenobiotica       Date:  2001 Aug-Sep       Impact factor: 1.908

Review 2.  [Peculiarities of cardiac glycoside therapy in the aged].

Authors:  E Erdmann
Journal:  Internist (Berl)       Date:  1991-08       Impact factor: 0.743

3.  Digitoxinlike and digoxinlike immunoreactivitis in sera of patients with uremia and liver disease as measured by fluorescence polarization immunoassays: poor correlation between digitoxinlike and digoxinlike immunoreactivities.

Authors:  M Luke; A Dasgupta
Journal:  Ther Drug Monit       Date:  1997-04       Impact factor: 3.681

4.  P-glycoprotein-mediated intestinal and biliary digoxin transport in humans.

Authors:  Siegfried Drescher; Hartmut Glaeser; Thomas Mürdter; Monika Hitzl; Michel Eichelbaum; Martin F Fromm
Journal:  Clin Pharmacol Ther       Date:  2003-03       Impact factor: 6.875

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 6.  Recognition and management of digitalis toxicity.

Authors:  R A Kelly; T W Smith
Journal:  Am J Cardiol       Date:  1992-06-04       Impact factor: 2.778

7.  P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin.

Authors:  C Pauli-Magnus; T Mürdter; A Godel; T Mettang; M Eichelbaum; U Klotz; M F Fromm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-03       Impact factor: 3.000

8.  Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries.

Authors:  J L Warren; A M McBean; S L Hass; J D Babish
Journal:  Arch Intern Med       Date:  1994-07-11

9.  The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin.

Authors:  I A de Lannoy; M Silverman
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

10.  Prevalence of appropriate and inappropriate indications for use of digoxin in older patients at the time of admission to a nursing home.

Authors:  W S Aronow
Journal:  J Am Geriatr Soc       Date:  1996-05       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.